Shandong Shanda Wit Science and Technology Co Ltd (000915) - Net Assets

Latest as of September 2025: CN¥4.21 Billion CNY ≈ $615.58 Million USD

Based on the latest financial reports, Shandong Shanda Wit Science and Technology Co Ltd (000915) has net assets worth CN¥4.21 Billion CNY (≈ $615.58 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥4.78 Billion ≈ $699.46 Million USD) and total liabilities (CN¥573.21 Million ≈ $83.88 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Shandong Shanda Wit Science and Technolo (000915) asset resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥4.21 Billion
% of Total Assets 88.01%
Annual Growth Rate 15.46%
5-Year Change 50.33%
10-Year Change 162.71%
Growth Volatility 20.71

Shandong Shanda Wit Science and Technology Co Ltd - Net Assets Trend (1996–2024)

This chart illustrates how Shandong Shanda Wit Science and Technology Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Shandong Shanda Wit Science and Technolo assets under control for the complete picture of this company's asset base.

Annual Net Assets for Shandong Shanda Wit Science and Technology Co Ltd (1996–2024)

The table below shows the annual net assets of Shandong Shanda Wit Science and Technology Co Ltd from 1996 to 2024. For live valuation and market cap data, see Shandong Shanda Wit Science and Technolo (000915) total market value.

Year Net Assets Change
2024-12-31 CN¥4.41 Billion
≈ $645.68 Million
-1.87%
2023-12-31 CN¥4.50 Billion
≈ $658.00 Million
+10.71%
2022-12-31 CN¥4.06 Billion
≈ $594.32 Million
+19.48%
2021-12-31 CN¥3.40 Billion
≈ $497.44 Million
+15.81%
2020-12-31 CN¥2.94 Billion
≈ $429.52 Million
+14.34%
2019-12-31 CN¥2.57 Billion
≈ $375.65 Million
+9.67%
2018-12-31 CN¥2.34 Billion
≈ $342.53 Million
+5.51%
2017-12-31 CN¥2.22 Billion
≈ $324.66 Million
+13.82%
2016-12-31 CN¥1.95 Billion
≈ $285.25 Million
+16.06%
2015-12-31 CN¥1.68 Billion
≈ $245.77 Million
+13.31%
2014-12-31 CN¥1.48 Billion
≈ $216.90 Million
+27.77%
2013-12-31 CN¥1.16 Billion
≈ $169.76 Million
+22.63%
2012-12-31 CN¥946.05 Million
≈ $138.44 Million
+22.99%
2011-12-31 CN¥769.24 Million
≈ $112.56 Million
+18.43%
2010-12-31 CN¥649.52 Million
≈ $95.05 Million
+23.32%
2009-12-31 CN¥526.71 Million
≈ $77.07 Million
+18.88%
2008-12-31 CN¥443.06 Million
≈ $64.83 Million
+12.58%
2007-12-31 CN¥393.55 Million
≈ $57.59 Million
+8.30%
2006-12-31 CN¥363.40 Million
≈ $53.18 Million
+5.79%
2005-12-31 CN¥343.51 Million
≈ $50.27 Million
+10.66%
2004-12-31 CN¥310.43 Million
≈ $45.43 Million
+3.60%
2003-12-31 CN¥299.64 Million
≈ $43.85 Million
+18.25%
2002-12-31 CN¥253.39 Million
≈ $37.08 Million
+3.22%
2001-12-31 CN¥245.49 Million
≈ $35.92 Million
-5.10%
2000-12-31 CN¥258.69 Million
≈ $37.85 Million
-1.64%
1999-12-31 CN¥262.99 Million
≈ $38.48 Million
+114.50%
1998-12-31 CN¥122.61 Million
≈ $17.94 Million
+19.29%
1997-12-31 CN¥102.78 Million
≈ $15.04 Million
+30.33%
1996-12-31 CN¥78.86 Million
≈ $11.54 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Shandong Shanda Wit Science and Technology Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 248611771600.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥2.49 Billion 85.39%
Common Stock CN¥234.33 Million 8.05%
Other Comprehensive Income CN¥164.49 Million 5.65%
Other Components CN¥26.72 Million 0.92%
Total Equity CN¥2.91 Billion 100.00%

Shandong Shanda Wit Science and Technology Co Ltd Competitors by Market Cap

The table below lists competitors of Shandong Shanda Wit Science and Technology Co Ltd ranked by their market capitalization.

Company Market Cap
Everlight Electronics Co Ltd
TW:2393
$993.22 Million
Star Petroleum Refining Co Ltd
BK:SPRC
$993.33 Million
CBL & Associates Properties Inc
NYSE:CBL
$993.50 Million
Soulbrain Holdings Co. Ltd
KQ:036830
$993.52 Million
Banco Patagonia
BA:BPAT
$992.69 Million
Graincorp Ltd
AU:GNC
$992.51 Million
Tianshui Zhongxing Bio-technology Co Ltd
SHE:002772
$992.05 Million
Nitratos de Chile SA
SN:NITRATOS
$991.87 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Shandong Shanda Wit Science and Technology Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 2,981,885,170 to 2,911,651,440, a change of -70,233,730 (-2.4%).
  • Net income of 515,594,981 contributed positively to equity growth.
  • Dividend payments of 585,796,786 reduced retained earnings.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥515.59 Million +17.71%
Dividends Paid CN¥585.80 Million -20.12%
Other Changes CN¥-31.92K -0.0%
Total Change CN¥- -2.36%

Book Value vs Market Value Analysis

This analysis compares Shandong Shanda Wit Science and Technology Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.33x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 92.98x to 2.33x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1996-12-31 CN¥0.31 CN¥28.96 x
1997-12-31 CN¥0.40 CN¥28.96 x
1998-12-31 CN¥0.49 CN¥28.96 x
1999-12-31 CN¥1.11 CN¥28.96 x
2000-12-31 CN¥1.09 CN¥28.96 x
2001-12-31 CN¥1.08 CN¥28.96 x
2002-12-31 CN¥1.75 CN¥28.96 x
2003-12-31 CN¥1.78 CN¥28.96 x
2004-12-31 CN¥1.82 CN¥28.96 x
2005-12-31 CN¥1.92 CN¥28.96 x
2006-12-31 CN¥1.28 CN¥28.96 x
2007-12-31 CN¥1.33 CN¥28.96 x
2008-12-31 CN¥1.43 CN¥28.96 x
2009-12-31 CN¥1.49 CN¥28.96 x
2010-12-31 CN¥1.78 CN¥28.96 x
2011-12-31 CN¥2.18 CN¥28.96 x
2012-12-31 CN¥2.68 CN¥28.96 x
2013-12-31 CN¥3.28 CN¥28.96 x
2014-12-31 CN¥4.14 CN¥28.96 x
2015-12-31 CN¥4.73 CN¥28.96 x
2016-12-31 CN¥5.50 CN¥28.96 x
2017-12-31 CN¥6.41 CN¥28.96 x
2018-12-31 CN¥6.78 CN¥28.96 x
2019-12-31 CN¥7.39 CN¥28.96 x
2020-12-31 CN¥8.33 CN¥28.96 x
2021-12-31 CN¥9.58 CN¥28.96 x
2022-12-31 CN¥11.03 CN¥28.96 x
2023-12-31 CN¥12.74 CN¥28.96 x
2024-12-31 CN¥12.42 CN¥28.96 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Shandong Shanda Wit Science and Technology Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 17.71%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 24.16%
  • • Asset Turnover: 0.43x
  • • Equity Multiplier: 1.69x
  • Recent ROE (17.71%) is above the historical average (12.27%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1996 26.61% 13.36% 0.73x 2.74x CN¥11.80 Million
1997 21.98% 13.65% 0.66x 2.44x CN¥10.89 Million
1998 19.60% 15.96% 0.58x 2.13x CN¥10.78 Million
1999 7.21% 17.79% 0.28x 1.47x CN¥-7.04 Million
2000 -1.13% -7.00% 0.10x 1.60x CN¥-27.71 Million
2001 0.59% 3.46% 0.09x 1.97x CN¥-23.10 Million
2002 2.12% 5.34% 0.18x 2.23x CN¥-19.86 Million
2003 1.42% 2.12% 0.24x 2.79x CN¥-22.02 Million
2004 1.72% 1.90% 0.31x 2.88x CN¥-21.73 Million
2005 2.22% 1.83% 0.35x 3.44x CN¥-21.51 Million
2006 3.62% 1.96% 0.56x 3.26x CN¥-18.27 Million
2007 4.05% 2.48% 0.50x 3.28x CN¥-18.01 Million
2008 4.31% 2.54% 0.52x 3.28x CN¥-18.04 Million
2009 9.78% 6.89% 0.45x 3.15x CN¥-761.86K
2010 16.89% 12.59% 0.49x 2.73x CN¥28.78 Million
2011 18.32% 13.08% 0.62x 2.27x CN¥42.58 Million
2012 19.20% 14.65% 0.62x 2.12x CN¥58.27 Million
2013 19.95% 13.99% 0.69x 2.07x CN¥76.45 Million
2014 22.47% 15.82% 0.70x 2.02x CN¥120.62 Million
2015 13.83% 12.36% 0.59x 1.89x CN¥42.25 Million
2016 15.45% 12.84% 0.62x 1.93x CN¥69.99 Million
2017 16.22% 13.76% 0.64x 1.85x CN¥93.26 Million
2018 8.12% 8.50% 0.53x 1.81x CN¥-30.10 Million
2019 11.79% 11.34% 0.57x 1.82x CN¥30.99 Million
2020 14.89% 15.97% 0.49x 1.89x CN¥95.50 Million
2021 16.94% 18.76% 0.52x 1.75x CN¥155.79 Million
2022 20.39% 22.51% 0.50x 1.82x CN¥268.46 Million
2023 19.63% 23.56% 0.48x 1.74x CN¥287.07 Million
2024 17.71% 24.16% 0.43x 1.69x CN¥224.43 Million

Industry Comparison

This section compares Shandong Shanda Wit Science and Technology Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $1,347,197,696
  • Average return on equity (ROE) among peers: 4.46%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Shandong Shanda Wit Science and Technology Co Ltd (000915) CN¥4.21 Billion 26.61% 0.14x $993.04 Million
Shenzhen Neptunus Bioengineering Co Ltd (000078) $2.84 Billion -41.97% 9.13x $1.22 Billion
Anhui Fengyuan Pharmaceutical Co Ltd (000153) $638.89 Million 0.88% 0.70x $438.59 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423) $1.05 Billion 10.46% 0.19x $5.18 Billion
Livzon Pharmaceutical Group Inc (000513) $1.07 Billion 3.83% 0.46x $2.81 Billion
Wedge Industrial Co Ltd (000534) $1.29 Billion 11.69% 1.47x $2.95 Billion
Yunnan Baiyao Group Co Ltd (000538) $35.11 Million 18.13% 0.80x $13.85 Billion
Hainan Haiyao Co Ltd (000566) $5.08 Billion 1.71% 1.08x $949.23 Million
Tus Pharmaceutical Group Co Ltd (000590) $141.91 Million 11.01% 0.32x $391.07 Million
Northeast Pharmaceutical Group Co Ltd (000597) $994.58 Million 2.01% 2.11x $1.03 Billion
Jilin Aodong Pharmaceutical Group Co Ltd (000623) $332.48 Million 26.89% 0.68x $3.30 Billion

About Shandong Shanda Wit Science and Technology Co Ltd

SHE:000915 China Drug Manufacturers - Specialty & Generic
Market Cap
$993.04 Million
CN¥6.79 Billion CNY
Market Cap Rank
#9152 Global
#2459 in China
Share Price
CN¥28.96
Change (1 day)
+1.12%
52-Week Range
CN¥28.10 - CN¥35.60
All Time High
CN¥45.34
About

Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, licorice zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration s… Read more